Seegene’s Q1 sales increased by nearly 30% year-on-year to KRW 116 billion ($103 million), with operating profit at KRW 14.8 billion and net income at KRW 28.9 billion. Diagnostic reagent sales grew by 30.4% to KRW 83.2 billion, with non-COVID diagnostic reagent sales up 37.5%. Sales by region were highest in Europe at 64%, followed by Asia at 15%, Korea at 9%, Latin America at 7%, and North America at 4%.
Original Article: Read More
Auto-posted at: 2025-05-09 21:02:50